Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...
Drug resistance remains the foremost challenge to durable cancer control. Tumors evolve dynamic mechanisms to evade therapy through target mutations, ...
Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid ...
"A successful career starts with the outlook that opportunities are always present, even in the face of uncertainty. Life is ...
A joint operation between the Berea Police Department and the Berea Street Crimes Unit led to a major drug bust at a local ...
Nanobodies—tiny proteins derived from animals in the camelid family including camels, llamas, and alpacas—could be useful in treating brain disorders like schizophrenia and Alzheimer’s disease. In a ...
CR-001 Demonstrated Cooperative Pharmacology and Robust Anti-Tumor Activity IND Submission for CR-001 On Track for Fourth Quarter of 2025 to ...
Nitazenes, a class of synthetic drugs 40 times more potent than fentanyl, are steadily becoming more common on both sides of ...
McCormick said in a press conference Thursday that he was concerned nitazenes “would become the next fentanyl,” the opioid behind a massive rise in overdose deaths across the U.S.
Rising tensions between the NHS and pharmaceutical companies are testing how much the health service can afford to pay for new branded medicines.
A 19th century dye is the latest wellness craze - but scientists say the hype around the synthetic compound as an anti-aging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback